NHP2 and cancer: Because NHP2 is essential, MYC-tagged wild-type NHP2 (NHP2-WT) or mutant NHP2 (NHP2-A39T or NHP2-T44M) were expressed in telomerase-positive HeLa cancer cell line first, and then the bulk endogenous NHP2 was targeted with CRISPR/Cas9.